Cargando…

Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study

BACKGROUND: Cervical cancer is one of the most common cancers in Taiwan. Some patients take Chinese herbal medicine (CHM). However, very few current studies have ascertained the usage and efficacy of CHM in patients with cervical cancer. The aim of this study was to investigate the benefits of compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chieh, Lin, Kent Yu-Hsien, Wu, Mei-Yao, Lin, Cheng-Li, Lin, Jaung-Geng, Chang, Cherry Yin-Yi, Lin, Wu-Chou, Yen, Hung-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721688/
https://www.ncbi.nlm.nih.gov/pubmed/34923874
http://dx.doi.org/10.1177/15347354211061752
_version_ 1784625392487759872
author Wang, Chieh
Lin, Kent Yu-Hsien
Wu, Mei-Yao
Lin, Cheng-Li
Lin, Jaung-Geng
Chang, Cherry Yin-Yi
Lin, Wu-Chou
Yen, Hung-Rong
author_facet Wang, Chieh
Lin, Kent Yu-Hsien
Wu, Mei-Yao
Lin, Cheng-Li
Lin, Jaung-Geng
Chang, Cherry Yin-Yi
Lin, Wu-Chou
Yen, Hung-Rong
author_sort Wang, Chieh
collection PubMed
description BACKGROUND: Cervical cancer is one of the most common cancers in Taiwan. Some patients take Chinese herbal medicine (CHM). However, very few current studies have ascertained the usage and efficacy of CHM in patients with cervical cancer. The aim of this study was to investigate the benefits of complementary CHM among patients with cervical cancer in Taiwan. METHODS: We included the newly diagnosed cervical cancer patients who were registered in the Taiwanese Registry for Catastrophic Illness Patients Database between 2000 and 2010. The end of follow-up period was December 31, 2011. Patients who were less than 20 years old, had missing information for age, withdrew from the National Health Insurance (NHI) program during the follow-up period, or only received other TCM interventions such as acupuncture or tuina massage were excluded from our study. After performing 1:1 frequency matching by age and index date, we enrolled 7521 patients in both CHM and non-CHM user groups. A Cox regression model was used to compare the hazard ratios (HRs) of the risk of mortality. The Kaplan-Meier curve was used to compare the difference in survival time. RESULTS: According to the Cox hazard ratio model mutually adjusted for CHM use, age, comorbidity, treatment, and chemotherapeutic agents used, we found that CHM users had a lower hazard ratio of mortality risk (adjusted HR = 0.29, 95%CI = 0.27-0.31). The survival probability was higher for patients in the CHM group. Bai-Hua-She-She-Cao (Herba Oldenlandiae, synonym Herba Hedyotis diffusae) and Jia-Wei-Xiao-Yao-San were the most commonly prescribed single herb and Chinese herbal formula, respectively. CONCLUSIONS: Adjunctive CHM may have positive effects of reducing mortality rate and improving the survival probability for cervical cancer patients. Further evidence-based pharmacological investigations and clinical trials are warranted to confirm the findings in our study.
format Online
Article
Text
id pubmed-8721688
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87216882022-01-04 Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study Wang, Chieh Lin, Kent Yu-Hsien Wu, Mei-Yao Lin, Cheng-Li Lin, Jaung-Geng Chang, Cherry Yin-Yi Lin, Wu-Chou Yen, Hung-Rong Integr Cancer Ther Research Article BACKGROUND: Cervical cancer is one of the most common cancers in Taiwan. Some patients take Chinese herbal medicine (CHM). However, very few current studies have ascertained the usage and efficacy of CHM in patients with cervical cancer. The aim of this study was to investigate the benefits of complementary CHM among patients with cervical cancer in Taiwan. METHODS: We included the newly diagnosed cervical cancer patients who were registered in the Taiwanese Registry for Catastrophic Illness Patients Database between 2000 and 2010. The end of follow-up period was December 31, 2011. Patients who were less than 20 years old, had missing information for age, withdrew from the National Health Insurance (NHI) program during the follow-up period, or only received other TCM interventions such as acupuncture or tuina massage were excluded from our study. After performing 1:1 frequency matching by age and index date, we enrolled 7521 patients in both CHM and non-CHM user groups. A Cox regression model was used to compare the hazard ratios (HRs) of the risk of mortality. The Kaplan-Meier curve was used to compare the difference in survival time. RESULTS: According to the Cox hazard ratio model mutually adjusted for CHM use, age, comorbidity, treatment, and chemotherapeutic agents used, we found that CHM users had a lower hazard ratio of mortality risk (adjusted HR = 0.29, 95%CI = 0.27-0.31). The survival probability was higher for patients in the CHM group. Bai-Hua-She-She-Cao (Herba Oldenlandiae, synonym Herba Hedyotis diffusae) and Jia-Wei-Xiao-Yao-San were the most commonly prescribed single herb and Chinese herbal formula, respectively. CONCLUSIONS: Adjunctive CHM may have positive effects of reducing mortality rate and improving the survival probability for cervical cancer patients. Further evidence-based pharmacological investigations and clinical trials are warranted to confirm the findings in our study. SAGE Publications 2021-12-19 /pmc/articles/PMC8721688/ /pubmed/34923874 http://dx.doi.org/10.1177/15347354211061752 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Article
Wang, Chieh
Lin, Kent Yu-Hsien
Wu, Mei-Yao
Lin, Cheng-Li
Lin, Jaung-Geng
Chang, Cherry Yin-Yi
Lin, Wu-Chou
Yen, Hung-Rong
Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title_full Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title_fullStr Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title_full_unstemmed Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title_short Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
title_sort adjunctive chinese herbal medicine treatment is associated with an improved survival rate in patients with cervical cancer in taiwan: a matched cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721688/
https://www.ncbi.nlm.nih.gov/pubmed/34923874
http://dx.doi.org/10.1177/15347354211061752
work_keys_str_mv AT wangchieh adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT linkentyuhsien adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT wumeiyao adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT linchengli adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT linjaunggeng adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT changcherryyinyi adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT linwuchou adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy
AT yenhungrong adjunctivechineseherbalmedicinetreatmentisassociatedwithanimprovedsurvivalrateinpatientswithcervicalcancerintaiwanamatchedcohortstudy